COLLABORATIVE
PROJECTS
Together, Let's Co-Develop by Exploring Neuroscience and Leveraging Preclinical EEG
Digging into Science requires time, resources and the right investigational strategy or methodology, which are not always available in-house. SynapCell was also created to establish and collaborate on innovative projects, to pave the way for better and faster preclinical drug discovery studies.
Open innovation PROGRAM
Join our Open Innovation Program in Neuroscience
Over the past years, SynapCell’s portfolio has been a unique mixture of internal programs and fruitful collaborations with Sponsors. We have consistently helped scientists and drug discoverers to go further in translational science.
Our Open Innovation programs represent the different studies and ideas we want to bring to life. Whether it is a specific endpoint, a model we have yet to work with, or a surgical procedure, we’re always up for a challenge.
Can’t find it in our portfolio or on our website? Ask us! Your project might be a good fit for a great collaboration!
Take Advantage of our Unique Expertise in Preclinical and Translational EEG for CNS Drug Discovery
Drawing on 20 years’ expertise in preclinical EEG, SynapCell offers you unique know-how to support your research and push back the boundaries of science.
Working with us means working with a dedicated team of scientists with expertise in multiple areas (animal surgery, signal recording & analysis, neuroscience, etc.). We make our platform and our people available for your specific project, to make it happen. Whether it is a standard off-the-shelf study or a tailored protocol, come with your question and we will develop the protocol to attempt to find an answer, together !
unique Preclinical EEG expertise
Exploring Therapeutic Potential
With SynapCell, take advantage of Resting state (RS), Event related (ERP), model exploration or Pharmaco-induced EEG Biomarkers to enhance your understanding of brain function and evaluate the pharmacodynamic efficacy of investigational compounds in Psychiatric, Neurodegenerative or other Brain Disorders… and much more!
Powered by Cue®, SynapCell's Predictive In Vivo EEG Platform
SynapCell’s rodent models and their associated EEG biomarkers are processed on on Cue®, our innovative translational in vivo EEG platform, which is designed to predict the in-human efficacy of your drug candidates during the preclinical step. Cue® is the result of decades of R&D, combining SynapCell’s know-how, expertise and scientific excellence in the fields of brain surgery and EEG signal recording, processing, and analysis.
Using Cue®, we transform preclinical data into actionable insights, offering end-to-end support for informed decision-making in CNS drug discovery.
Let's Talk About Your Research Project!
More than a CRO, a team of collaborators – we are your dream neuroscience team specialized in preclinical EEG! We don’t just produce data, we are your partners from conceptualization to conclusion. We translate raw EEG data into meaningful, clinically-relevant endpoints, delivering clear insights to allow data-based decision-making. Choose SynapCell, a leading preclinical CNS-specialized CRO for cutting-edge EEG expertise combined with an irresistible touch of fun.
News & Events